Glenmark introduces NINDANIB for treatment of Pulmonary Fibrosis in India
MUMBAI: Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, launched NINDANIB (Nintedanib 100 and 150 mg capsules) for the treatment of pulmonary fibrosis in India. Glenmark being a leader in the area of respiratory has been amongst the first to…